On January 3, the Dallas Morning News published Roundtable Senior Executive Fellow Howard Husock’s op-ed, “Why philanthropy was critical to developing COVID-19 vaccines,” which discusses how philanthropy can make investments and take risks when the government and business sectors cannot. Below you will find an excerpt. You can read the full text here.
On the surface, the development of the COVID-19 vaccine appears to have occurred at warp speed thanks to a combination of private risk and government investment. But like so many things that happen seemingly overnight, the scientific breakthroughs that led to the vaccine date back decades. It represents a key moment for philanthropy that underscores its capacity to focus on getting results by taking risks without the expectation of financial gain.
Read more here.
